Literature DB >> 31209831

Serum Irisin, Adropin, and Preptin in Obese Patients 6 Months After Bariatric Surgery.

M Glück1, J Glück2, M Wiewióra3, B Rogala2, J Piecuch3.   

Abstract

BACKGROUND/
OBJECTIVES: The reduction of body mass after bariatric surgery affects energy metabolism and may involve changes in irisin, preptin, and adropin production. SUBJECTS AND METHODS: Fifty-five morbidly obese patients with a mean body mass index (BMI) of 45.7 ± 5.8 kg/m2 were treated with either laparoscopic sleeve gastrectomy(n = 30) or laparoscopic adjustable gastric banding (n = 25). Forty-six (83.6%) were followed-up 6 months after surgery. The control group included 15 healthy non-obese participants. Anthropometric measurements, lipid profiles, HbA1c, and serum irisin, preptin, and adropin were assessed at baseline and on follow-up.
RESULTS: The serum concentrations of all three peptides were higher at 6 months than at baseline but only irisin (p = 0.02) and adropin (p = 0.000001) were significantly higher. The increase in preptin was borderline significant (p = 0.051). Changes of serum concentrations of all three peptides were bidirectional.
CONCLUSION: Body mass reduction resulting from bariatric procedures may change the production of energy regulating peptides, but not always in a favorable manner.

Entities:  

Keywords:  Adropin; Bariatric surgery; Irisin; Obesity; Preptin

Mesh:

Substances:

Year:  2019        PMID: 31209831     DOI: 10.1007/s11695-019-03998-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  22 in total

1.  Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.

Authors:  Andrew A Butler; Charmaine S Tam; Kimber L Stanhope; Bruce M Wolfe; Mohamed R Ali; Majella O'Keeffe; Marie-Pierre St-Onge; Eric Ravussin; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2012-08-07       Impact factor: 5.958

2.  The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation.

Authors:  G Barbatelli; I Murano; L Madsen; Q Hao; M Jimenez; K Kristiansen; J P Giacobino; R De Matteis; S Cinti
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-30       Impact factor: 4.310

Review 3.  New peptides players in metabolic disorders.

Authors:  Agata Mierzwicka; Marek Bolanowski
Journal:  Postepy Hig Med Dosw (Online)       Date:  2016-08-31       Impact factor: 0.270

4.  Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults.

Authors:  Mervat El-Eshmawy; Ibrahim Abdel Aal
Journal:  Appl Physiol Nutr Metab       Date:  2015-02-12       Impact factor: 2.665

5.  Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.

Authors:  C Xin; J Liu; J Zhang; D Zhu; H Wang; L Xiong; Y Lee; J Ye; K Lian; C Xu; L Zhang; Q Wang; Y Liu; L Tao
Journal:  Int J Obes (Lond)       Date:  2015-09-25       Impact factor: 5.095

6.  Circulating serum irisin levels in obesity and type 2 diabetes mellitus.

Authors:  Amira Shoukry; Sally M Shalaby; Shereen El-Arabi Bdeer; Amira A Mahmoud; Mayada M Mousa; Ashraf Khalifa
Journal:  IUBMB Life       Date:  2016-05-24       Impact factor: 3.885

7.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

8.  Effects of Body Weight Reduction on Serum Irisin and Metabolic Parameters in Obese Subjects.

Authors:  Yaeko Fukushima; Satoshi Kurose; Hiromi Shinno; Ha Cao Thi Thu; Nana Takao; Hiromi Tsutsumi; Takaaki Hasegawa; Toshiaki Nakajima; Yutaka Kimura
Journal:  Diabetes Metab J       Date:  2016-09-27       Impact factor: 5.376

9.  Association of Circulating Irisin Concentrations with Weight Loss after Roux-en-Y Gastric Bypass Surgery.

Authors:  Yeon Ji Lee; Yoonseok Heo; Ji-Ho Choi; Sunghyouk Park; Kyoung Kon Kim; Dong Wun Shin; Ju-Hee Kang
Journal:  Int J Environ Res Public Health       Date:  2019-02-24       Impact factor: 3.390

10.  Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population.

Authors:  Simon Oelmann; Matthias Nauck; Henry Völzke; Martin Bahls; Nele Friedrich
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

View more
  4 in total

1.  Changes of Circulating Irisin and High-Sensitivity C-Reactive Protein Levels in Morbidly Obese Individuals with Type 2 Diabetes After Roux-en-Y Gastric Bypass.

Authors:  Prapimporn Ch Shantavasinkul; Philip Omotosho; Leonor Corsino; Michael J Muehlbauer; Pairoj Chattranukulchai; Alfonso Torquati
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2022-02-11       Impact factor: 1.766

2.  Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice.

Authors:  Sarbani Ghoshal; Subhashis Banerjee; Jinsong Zhang; Michael L Niehoff; Susan A Farr; Andrew A Butler
Journal:  Peptides       Date:  2021-10-22       Impact factor: 3.750

Review 3.  Adropin's Role in Energy Homeostasis and Metabolic Disorders.

Authors:  Ifrah Ismail Ali; Crystal D'Souza; Jaipaul Singh; Ernest Adeghate
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

Review 4.  Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.

Authors:  Ana Rita de Oliveira Dos Santos; Bárbara de Oliveira Zanuso; Vitor Fernando Bordin Miola; Sandra Maria Barbalho; Patrícia C Santos Bueno; Uri Adrian Prync Flato; Claudia Rucco P Detregiachi; Daniela Vieira Buchaim; Rogério Leone Buchaim; Ricardo José Tofano; Claudemir Gregório Mendes; Viviane Alessandra Capelluppi Tofano; Jesselina F Dos Santos Haber
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.